Remifentanil
- Generic Name
- Remifentanil
- Brand Names
- Ultiva
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28N2O5
- CAS Number
- 132875-61-7
- Unique Ingredient Identifier
- P10582JYYK
- Background
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
- Indication
For use during the induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
Effect of Dexmedetomidine Combined With Low-dose Nalmefene on Preventing Remifentanil-induced Postoperative Hyperalgesia
- Conditions
- Interventions
- First Posted Date
- 2017-03-30
- Last Posted Date
- 2021-08-03
- Lead Sponsor
- Tianjin Medical University General Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT03096730
- Locations
- ๐จ๐ณ
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
A Study to Compare the Long-term Outcomes After Two Different Anaesthetics
- Conditions
- Interventions
- First Posted Date
- 2017-03-24
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Murdoch Childrens Research Institute
- Target Recruit Count
- 450
- Registration Number
- NCT03089905
- Locations
- ๐บ๐ธ
Boston Children's Hospital, Boston, Massachusetts, United States
๐บ๐ธThe University of Texas Southwestern Medical Center, Dallas, Texas, United States
๐บ๐ธCleveland Clinic, Cleveland, Ohio, United States
Effect of Ultra-low Dose Naloxone on Remifentanil-Induced Hyperalgesia
- Conditions
- Interventions
- First Posted Date
- 2017-02-28
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 105
- Registration Number
- NCT03066739
- Locations
- ๐บ๐ธ
UC Irvine Medical Center, Orange, California, United States
Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults
- First Posted Date
- 2017-02-27
- Last Posted Date
- 2017-09-13
- Lead Sponsor
- Brasilia University Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT03065309
- Locations
- ๐ง๐ท
Hospital das Forรงas Armadas, Brasilia, Distrito Federal, Brazil
Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Hernia Repair
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- Alberta Children's Hospital
- Target Recruit Count
- 88
- Registration Number
- NCT03041948
- Locations
- ๐จ๐ฆ
Alberta Children's Hospital, Calgary, Alberta, Canada
๐จ๐ฆRoyal University Hospital/University of Saskatchewan, Saskatoon, Saskatchewan, Canada
Evaluating Pain Outcomes of Caudal vs Ilioinguinal Nerve Block in Children Undergoing Orchiopexy Repair
- Conditions
- Interventions
- First Posted Date
- 2017-02-03
- Last Posted Date
- 2022-02-16
- Lead Sponsor
- Alberta Children's Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03041935
- Locations
- ๐จ๐ฆ
Alberta Children's Hospital, Calgary, Alberta, Canada
Comparison of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy
- Conditions
- Interventions
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2019-10-23
- Lead Sponsor
- King Hamad University Hospital, Bahrain
- Target Recruit Count
- 75
- Registration Number
- NCT03037892
- Locations
- ๐ง๐ญ
Awali Hospital, Manama, Bahrain
Anaesthesia for Laparoscopic Sleeve Gastrectomy
- Conditions
- Interventions
- First Posted Date
- 2017-01-24
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Menoufia University
- Target Recruit Count
- 100
- Registration Number
- NCT03029715
Intraoperative Methadone Administration for Improved Pain Control in Spinal Fusion Patients
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2023-05-22
- Lead Sponsor
- Montefiore Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT02989597
- Locations
- ๐บ๐ธ
Montefiore Medical Center, Bronx, New York, United States
Conscious Sedation for Epilepsy Surgery
- Conditions
- Interventions
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Menoufia University
- Target Recruit Count
- 60
- Registration Number
- NCT02988050
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.